Related Experiment Video
Updated: Aug 8, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Evodiamine induced human melanoma A375-S2 cell death partially through interleukin 1 mediated pathway
Che Wang1, Min-wei Wang, Shin-ichi Tashiro
1China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical University, China.
Abstract:
We have reported that caspase cascade accompanied by the regulation of Bax/Bcl-2 and MAPK signaling were involved in evodiamine-induced A375-S2 cell death. In this study, pretreatment with interleukin 1 (IL-1) receptor antagonist (IL-1Ra) rescued the cell viability loss and reversed the ratio of terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive cells induced by evodiamine. IL-1Ra was capable of attenuating the expression of Fas-ligand (Fas-L) and the cleavage of procaspas-8 and -3 caused by evodiamine. Subsequently, IL-1Ra reduced evodiamine-induced DNA degradation, p53 activation and up-regulation of Bax/Bcl-2 ratio. However, IL-1Ra attenuated the enhanced phosphorylation level of p38 mitogen-activated protein kinase (p38 MAPK) without affecting extracellular signal-regulated protein kinase (ERK) inactivation induced by evodiamine. In conclusion, IL-1-induced death cascade in melanoma A375-S2 cell might be one of the targets for natural product evodiamine, and increased Fas-L expression via IL-1 mediated pathway stands at the initiation phase, leading to consequent events that culminate in the death of the cells.
Insights
Evodiamine induces melanoma cell death via a caspase cascade and MAPK signaling. Interleukin-1 receptor antagonist (IL-1Ra) blocks this process by inhibiting Fas-ligand expression and downstream signaling pathways.
Area of Science:
- Cell Biology
- Pharmacology
- Immunology
Background:
- Evodiamine has been shown to induce apoptosis in A375-S2 melanoma cells.
- This cell death involves caspase cascades, Bax/Bcl-2 regulation, and MAPK signaling pathways.
Purpose of the Study:
- To investigate the role of interleukin-1 (IL-1) in evodiamine-induced melanoma cell death.
- To elucidate the specific molecular mechanisms by which IL-1 contributes to this process.
Main Methods:
- Treatment of A375-S2 melanoma cells with evodiamine and IL-1 receptor antagonist (IL-1Ra).
- Assessment of cell viability, TUNEL staining, Western blotting for caspase cleavage, p53 activation, Bax/Bcl-2 ratio, and MAPK phosphorylation (p38 MAPK, ERK).
Main Results:
- IL-1Ra pretreatment rescued cell viability and reduced TUNEL-positive cells induced by evodiamine.
- IL-1Ra attenuated evodiamine-induced Fas-ligand expression, procaspase cleavage, DNA degradation, p53 activation, and altered Bax/Bcl-2 ratio.
- IL-1Ra inhibited p38 MAPK phosphorylation but did not affect ERK inactivation.
Conclusions:
- IL-1 signaling is involved in evodiamine-induced melanoma cell death.
- Increased Fas-ligand expression via the IL-1 mediated pathway is an early event in evodiamine-induced cell death.
- Evodiamine may target the IL-1-induced death cascade in melanoma cells.
Related Concept Videos
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury IlI: Cellular Death
Cellular Injury V: Apoptosis and Autophagy
Cytotoxic Edema: Pathophysiology

